# Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Men

> **NCT02432261** · PHASE1 · COMPLETED · sponsor: **Kimberly Myer** · enrollment: 44 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Nestorone® /testosterone gel
- **DRUG:** Testosterone only gel

## Key facts

- **NCT ID:** NCT02432261
- **Lead sponsor:** Kimberly Myer
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-04
- **Primary completion:** 2016-03
- **Final completion:** 2016-03
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2025-02-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02432261

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02432261, "Evaluate the Pharmacokinetics and Gonadotropin Suppression of Nestorone®-Testosterone (NES/T) Combination Gel in Men". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02432261. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*